ETHYL 3-BROMO-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE, 95%, 500mg

ULTROXA(regR) Poly(2-methyl-2-oxazoline) Azide Terminated (n=approx. 50)500mg

3-Iodo-1-(trifluoromethyl)bicyclo[1.1.1]pentane, 97%, 1g

6-Fluorosalicylic acid, 97.0%, 500g

2-Bromo-3-cyclopropylpyridine, 95.0%, 250mg

2-BROMO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE HCL, 95.0%, 1g

N,N'-Bis[2-(dimethylamino)ethyl]-1,8:4,5-naphthalenetetracarboxdiimide>98.0%(HPLC)(N)200mg

2-(4-Biphenylyl)indole>98.0%(GC)5g

2',5'-dimethoxy-[1,1':4',1''-terphenyl]-4,4''-dicarbaldehyde, 97%, 10g

4-(Chloromethyl)-1,1'-biphenyl>98.0%(GC)5g

N1,N2-Bis(4-hydroxy-2,6-dimethylphenyl)oxalamide, 97.0%, 10g

Methyl 5-cyano-2-methylbenzoate, 97%, 5g

4-Iodophthalonitrile, 95.0%, 5g